Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prelox® for Improvement of Erectile Quality

View through CrossRef
Sexual desire typically persists when men grow older although their ability to attain and maintain erections sufficient to permit satisfactory sexual intercourse gradually declines. Decreasing erectile quality is a common age-related problem affecting the lives of both men and their partners. Lifestyle plays an important role in the onset of erectile quality problems, and timely improvements such as a healthier diet and exercise may significantly slow the progression to erectile dysfunction with increasing age. Essentially, all cardiovascular risk factors – including hypertension, dyslipidaemia, hyperglycaemia, obesity and cigarette smoking – impair endothelial function, which in turn directly translates into declining erectile function. In this regard a man’s penis does indeed represent a barometer indicating his cardiovascular health status. Once endothelial function has declined to a point where its restoration is not feasible, pharmacological interventions with phosphodiesterase-5 (PDE5) inhibitors may temporarily bypass physiological processes so that affected men may still enjoy sexual intercourse. A timely intervention that helps to restore endothelial function will have the advantage of preserving a man’s ability to spontaneously respond to sexual arousal. Prelox®, a patented complex formulation consisting of Pycnogenol® and L-arginine aspartate, has been demonstrated in four clinical trials to naturally restore healthy erectile quality in men presenting with moderate erectile problems. Pycnogenol, a key component of Prelox, was shown in human pharmacological studies to act as a catalyst on endothelial nitric oxide (NO) synthase for amplified synthesis of NO, the initial mediator for triggering an erection. Its combination with the enzyme’s substrate, L-arginine, synergistically increases synthesis of NO, the key component involved in vasodilatation for improved blood flow to engorge the penis. According to reviewed clinical trials, Prelox will help men with moderate erectile problems to regain healthy erectile function, greater confidence to initiate and sustain erections and more frequent morning erections. As a result of higher intercourse frequency, men taking Prelox developed significantly higher plasma testosterone values. Prelox is a safe, well-tolerated and efficacious treatment for mild to moderate cases of declining erectile quality.
Touch Medical Media, Ltd.
Title: Prelox® for Improvement of Erectile Quality
Description:
Sexual desire typically persists when men grow older although their ability to attain and maintain erections sufficient to permit satisfactory sexual intercourse gradually declines.
Decreasing erectile quality is a common age-related problem affecting the lives of both men and their partners.
Lifestyle plays an important role in the onset of erectile quality problems, and timely improvements such as a healthier diet and exercise may significantly slow the progression to erectile dysfunction with increasing age.
Essentially, all cardiovascular risk factors – including hypertension, dyslipidaemia, hyperglycaemia, obesity and cigarette smoking – impair endothelial function, which in turn directly translates into declining erectile function.
In this regard a man’s penis does indeed represent a barometer indicating his cardiovascular health status.
Once endothelial function has declined to a point where its restoration is not feasible, pharmacological interventions with phosphodiesterase-5 (PDE5) inhibitors may temporarily bypass physiological processes so that affected men may still enjoy sexual intercourse.
A timely intervention that helps to restore endothelial function will have the advantage of preserving a man’s ability to spontaneously respond to sexual arousal.
Prelox®, a patented complex formulation consisting of Pycnogenol® and L-arginine aspartate, has been demonstrated in four clinical trials to naturally restore healthy erectile quality in men presenting with moderate erectile problems.
Pycnogenol, a key component of Prelox, was shown in human pharmacological studies to act as a catalyst on endothelial nitric oxide (NO) synthase for amplified synthesis of NO, the initial mediator for triggering an erection.
Its combination with the enzyme’s substrate, L-arginine, synergistically increases synthesis of NO, the key component involved in vasodilatation for improved blood flow to engorge the penis.
According to reviewed clinical trials, Prelox will help men with moderate erectile problems to regain healthy erectile function, greater confidence to initiate and sustain erections and more frequent morning erections.
As a result of higher intercourse frequency, men taking Prelox developed significantly higher plasma testosterone values.
Prelox is a safe, well-tolerated and efficacious treatment for mild to moderate cases of declining erectile quality.

Related Results

Unraveling the intersection of sleep disorders and erectile dysfunction: Outcomes from two EPISONO editions
Unraveling the intersection of sleep disorders and erectile dysfunction: Outcomes from two EPISONO editions
AbstractBackgroundThere is growing interest in the relationship between sleep disorders and erectile dysfunction. We present the results from a 2015 follow‐up study in relation to ...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Inhibition of RIP1/RIP3 Necroptosis Pathway Promote Erectile Function in Cold‐Stressed Rat Model
Inhibition of RIP1/RIP3 Necroptosis Pathway Promote Erectile Function in Cold‐Stressed Rat Model
Cold stimulation is the most common stressor in cold regions. Continuous cold stimulation can cause a series of pathophysiological changes in the body, such as aggregated neutrophi...
Evaluation of Choroidal Vascularity Index, Retinal and Optic Nerve Changes in Erectile Dysfunction
Evaluation of Choroidal Vascularity Index, Retinal and Optic Nerve Changes in Erectile Dysfunction
Abstract Objective: To investigate choroidal alterations through assessment of subfoveal choroidal thickness (SFCT) and choroidal vascularity index (CVI), optic nerve modif...

Back to Top